Press Releases from Exactitude Consultancy (19495 total)
Tay-Sachs disease market is expected to reach USD 710 million by 2034
Tay-Sachs disease is a rare, inherited lysosomal storage disorder caused by mutations in the HEXA gene, leading to deficiency of the enzyme beta-hexosaminidase A. This…
Von Willebrand Disease (VWD) Market 2025-2034 Business Outlook, Critical Insight …
Introduction
Von Willebrand Disease (VWD) is the most common inherited bleeding disorder, caused by deficiencies or dysfunction in the von Willebrand factor (VWF), a protein essential…
Recessive Dystrophic Epidermolysis Bullosa (RDEB) market is expected to reach US …
Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a rare, inherited connective tissue disorder caused by mutations in the COL7A1 gene, which impairs the production of type…
Sickle Cell Disease (SCD) Market 2025-2034 Business Outlook, Critical Insight an …
Introduction
Sickle Cell Disease (SCD) is a group of inherited blood disorders caused by mutations in the hemoglobin gene, leading to abnormally shaped red blood cells.…
Prader-Willi Syndrome (PWS) Market Insights and Future Outlook
Introduction
Prader-Willi Syndrome (PWS) is a complex and rare genetic disorder caused by the loss of function of specific genes on chromosome 15. It is characterized…
Epidermolysis Bullosa (EB) Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Epidermolysis Bullosa (EB) is a group of rare, inherited skin disorders characterized by extreme fragility of the skin, leading to blistering and wounds even from…
Hereditary Transthyretin Amyloidosis (hATTR) Market New Product Development & La …
Introduction
Hereditary Transthyretin Amyloidosis (hATTR) is a rare, life-threatening genetic condition caused by mutations in the transthyretin (TTR) gene. These mutations lead to misfolded proteins that…
Alpha-1 Antitrypsin Deficiency (AATD) Market Emerging Trends and Growth Prospect …
Introduction
Alpha-1 Antitrypsin Deficiency (AATD) is a rare genetic disorder that can cause progressive lung conditions such as emphysema, chronic obstructive pulmonary disease (COPD), and liver…
Microscopic Polyangiitis (MPA) market is expected to reach USD 1.45 billion by 2 …
Microscopic polyangiitis (MPA) is a rare, systemic autoimmune disorder characterized by necrotizing vasculitis of small- and medium-sized blood vessels. It often affects the kidneys, lungs,…
Lassa fever market is expected to reach USD 210 million by 2034
Lassa fever is an acute viral hemorrhagic illness caused by the Lassa virus, an arenavirus endemic to West Africa. It spreads primarily through contact with…
Invasive Aspergillosis (IA) Market is expected to reach USD 7.5 billion by 2034
Invasive aspergillosis (IA) is a severe fungal infection caused by Aspergillus species, primarily affecting immunocompromised patients such as those with hematologic malignancies, stem cell or…
Human Papillomavirus 16 (HPV16) Positive Cancers Market is expected to reach USD …
Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide, and HPV16 is the most oncogenic strain, responsible for more than 50% of cervical…
Herpes Simplex Virus (HSV) market is expected to reach USD 9.0 billion by 2034
Herpes simplex virus (HSV) is a common viral infection caused by two types: HSV-1, which typically causes oral herpes (cold sores), and HSV-2, which primarily…
Helicobacter pylori (H. pylori) Infections Market is expected to reach $9.1 bill …
Helicobacter pylori (H. pylori) is a spiral-shaped bacterium that colonizes the stomach lining, causing chronic gastritis, peptic ulcers, and significantly increasing the risk of gastric…
Epidemic Keratoconjunctivitis (EKC) market is expected to reach USD 1.2 billion …
Epidemic keratoconjunctivitis (EKC) is a highly contagious ocular infection caused primarily by adenoviruses, presenting with severe conjunctival inflammation, corneal involvement, pain, and vision disturbances. Outbreaks…
Community-Acquired Bacterial Pneumonia (CABP) Market is expected to reach USD 14 …
Community-acquired bacterial pneumonia (CABP) is a serious lung infection contracted outside hospital or healthcare settings, most commonly caused by Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae,…
Chronic Hepatitis B (CHB) market is expected to reach USD 9.8 billion by 2034
Chronic Hepatitis B (CHB) is a serious liver infection caused by the hepatitis B virus (HBV) that persists for more than six months. It can…
Athlete's Foot (Tinea Pedis) Market is expected to reach USD 5.9 billion by 2034
Athlete's foot, or tinea pedis, is a highly common contagious fungal infection of the feet caused mainly by Trichophyton species. Symptoms include itching, redness, scaling,…
Acute Bacterial Skin and Skin Structure Infections Market is expected to reach $ …
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) are severe bacterial infections of the skin and underlying tissues, including cellulitis, wound infections, and major abscesses.…
Onychomycosis Market is expected to reach USD 8.4 billion by 2034
Onychomycosis is a common fungal infection of the nails, caused primarily by dermatophytes, yeasts, and non-dermatophyte molds. It leads to nail discoloration, thickening, brittleness, and…
Human Immunodeficiency Virus Type 1 (HIV-1) Market is expected to reach USD 44.7 …
Human Immunodeficiency Virus Type 1 (HIV-1) remains a major global health challenge, responsible for the vast majority of HIV infections worldwide. While it is no…
Genital Herpes Market is expected to double, reaching USD 5.8 billion by 2034
Genital herpes is a chronic, sexually transmitted viral infection caused primarily by the herpes simplex virus type 2 (HSV-2), and in some cases by HSV-1.…
Catheter-Related Bloodstream Infection (CRBSI) Market is expected to reach USD 3 …
Catheter-related bloodstream infections (CRBSIs) are among the most serious and common hospital-acquired infections, caused when pathogens enter the bloodstream through central venous catheters (CVCs), peripherally…
Neurofibroma Market to Reach USD 1.1 Billion by 2034
The global Neurofibroma Market is experiencing steady momentum, driven by increasing prevalence of neurofibromatosis, advancements in molecular diagnostics, and rising research funding for rare genetic…
Molybdenum Cofactor Deficiency Type A (MoCD-A) Market New Product Development & …
Introduction
Molybdenum Cofactor Deficiency Type A (MoCD-A) is a rare, life-threatening metabolic disorder that presents significant clinical challenges due to its early onset, rapid progression, and…
Mucopolysaccharidosis I (MPS I) Market Emerging Trends and Growth Prospects 2034
Introduction
Mucopolysaccharidosis I (MPS I) is a rare lysosomal storage disorder caused by the deficiency of the enzyme α-L-iduronidase, leading to progressive multisystemic complications including skeletal…
Pachyonychia Congenita Market to Reach USD 750 Million by 2034
The Pachyonychia Congenita (PC) Market represents a highly specialized niche within the rare genetic disorders segment. Characterized by painful thickened nails, oral leukokeratosis, plantar keratoderma,…
Myotonic Dystrophy Market Detailed Industry Report Analysis 2025-2034
Introduction
Myotonic dystrophy (DM) is one of the most common forms of adult-onset muscular dystrophy, characterized by progressive muscle weakness, myotonia, cardiac issues, respiratory complications, and…
Neurofibromatosis Type 2 (NF2) Market Massive Growth opportunity Ahead
Introduction
Neurofibromatosis Type 2 (NF2) is a rare genetic disorder caused by mutations in the NF2 gene, leading to the development of benign tumours on the…
Sanfilippo Syndrome Market to Reach USD 3 Billion by 2034
The Sanfilippo Syndrome Market is entering a phase of growing attention from both the healthcare industry and patient advocacy groups. Sanfilippo syndrome (also known as…
PCSK9 Inhibitors Market Growth, Applications, Innovations and Business Outlook b …
Introduction
Cardiovascular diseases remain the leading cause of mortality worldwide, with elevated low-density lipoprotein cholesterol (LDL-C) being one of the most significant risk factors. While statins…
Thalassemia Market to Reach USD 9.1 Billion by 2034
The Thalassemia Market is entering a critical phase of expansion as healthcare systems worldwide focus on rare genetic blood disorders. Thalassemia, an inherited hemoglobin disorder,…
Progressive Familial Intrahepatic Cholestasis (PFIC) Market Growth, Trends, Cons …
Introduction
Progressive Familial Intrahepatic Cholestasis (PFIC) is a group of rare, inherited liver disorders characterized by defective bile secretion, leading to chronic cholestasis, liver damage, and…
Proteus Syndrome Market Set to Witness Significant Growth by 2025-2034
Introduction
Proteus syndrome is an extremely rare, progressive genetic disorder caused by mosaic mutations in the AKT1 gene, leading to asymmetric overgrowth of bones, skin, blood…
Vascular Ehlers-Danlos Syndrome (vEDS) Market to Reach USd 2.8 Billion by 2034
The Vascular Ehlers-Danlos Syndrome (vEDS) Market is evolving as healthcare systems place greater emphasis on rare connective tissue disorders. vEDS is the most severe subtype…
Rett Syndrome Market 2025-2034 Business Outlook, Critical Insight and Growth
Introduction
Rett syndrome is a rare, progressive neurodevelopmental disorder that almost exclusively affects girls, with an incidence of roughly 1 in 10,000 to 15,000 live female…
Usher Syndrome Market Insights and Future Outlook
Introduction
Usher syndrome is a rare genetic disorder and the leading cause of combined deafness and blindness worldwide. It is caused by mutations in genes responsible…
Von Willebrand Disease (VWD) Market Growth, Trends, Consumer Demand and Key Oppo …
Introduction
Von Willebrand Disease (VWD) is the most common inherited bleeding disorder, affecting both men and women across all age groups. The disease results from either…
Alpha-1 Antitrypsin Deficiency (AATD) Market Set to Witness Significant Growth b …
Introduction
Alpha-1 Antitrypsin Deficiency (AATD) is a rare genetic disorder caused by mutations in the SERPINA1 gene, leading to low levels or dysfunction of the alpha-1…
AL Amyloidosis Market 2025-2034 Business Outlook, Critical Insight and Growth
Introduction
AL Amyloidosis, also known as primary systemic amyloidosis, is a rare and life-threatening disorder caused by the misfolding of immunoglobulin light chains produced by plasma…
Argininosuccinic Aciduria (ASA) Market Insights and Future Outlook
Introduction
Argininosuccinic aciduria (ASA) is a rare urea cycle disorder caused by mutations in the ASL (argininosuccinate lyase) gene, which impairs the body's ability to break…
Cone-Rod Dystrophies (CRDs) Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Cone-rod dystrophies (CRDs) are a rare group of inherited retinal disorders marked by the progressive loss of cone photoreceptors (responsible for color and central vision)…
Netherton Syndrome Market is expected to reach USD 2.5 billion by 2034
Netherton Syndrome is a rare, inherited autosomal recessive skin disorder caused by mutations in the SPINK5 gene, which encodes the serine protease inhibitor LEKTI. The…
DDR-Defective Tumors Market New Product Development & Latest Trends
Introduction
DNA Damage Response (DDR) pathways are critical for maintaining genome integrity. When these pathways are defective, mutations accumulate, leading to tumor development. DDR-defective tumors are…
Lipodystrophy Syndrome (LS) Market to Reach USD 2.5 Billion by 2034
Lipodystrophy Syndromes (LS) are a group of rare disorders characterized by the selective loss or redistribution of adipose tissue, often leading to severe metabolic complications…
Hutchinson-Gilford Progeria Syndrome (HGPS) market is expected to reach USD 1.1 …
Hutchinson-Gilford Progeria Syndrome (HGPS), commonly known as progeria, is an ultra-rare genetic disorder caused by a mutation in the LMNA gene. This mutation leads to…
Familial Adenomatous Polyposis (FAP) market is expected to reach USD 2.5 billion …
Familial Adenomatous Polyposis (FAP) is a rare inherited disorder caused by mutations in the APC gene, leading to the development of hundreds to thousands of…
Eisenmenger Complex Market Emerging Trends and Growth Prospects 2034
Eisenmenger complex is a rare and severe complication of congenital heart disease, typically arising from untreated ventricular septal defects (VSDs), atrial septal defects (ASDs), or…
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Market Detailed Ind …
Introduction
Familial hypercholesterolemia (FH), also referred to as Type II hyperlipoproteinemia, is a genetic disorder of lipid metabolism characterized by very high levels of low-density lipoprotein…
Edward's Syndrome (Trisomy 18) Market to Reach USD 2.9 Billion by 2034
Edward's Syndrome, also known as Trisomy 18, is a rare chromosomal disorder caused by the presence of an extra copy of chromosome 18. It affects…
Go To Page: 21 22 23 24 25 26 27 28 29 30 241 242 243 244 245 246 247 248 249 250
